Skip to content

kidneycop

kidney cop calcium oxalate protector
Menu
  • Home
  • Science
    • How It Works
    • 99% Reduction
    • Clinically Researched Ingredients
    • Patented Innovation
    • Kidney C.O.P.® vs Chanca Piedra
    • FDA GRAS Ingredients
    • FDA CGMP Certified
    • Optimized for Health
    • Stability Testing
    • Made In The USA
    • Directions & Use
  • Stone FAQS
    • Types of Kidney Stones
    • What does a kidney stone looks like?
    • What Causes Kidney Stones?
    • Diet Lifestyle & Risk Factors
    • Questions and Answers
  • Oxalates
    • Oxalate Food Chart PDF
    • Oxalate Food Chart: Oxalate Values for Foods You Should Know
    • Oxalate Reduction Diet
    • Oxalates & Hydration
    • What Are Calcium Oxalate Crystals?
    • Calcium Oxalate Prevalence & Recurrence
    • Calcium Oxalate in the Excretory system
  • Resources
    • Reviews
    • Guarantee
    • Blog
    • Amazon Orders
    • About
      • Founder’s Story
      • Our Team
      • Mission & Goals
    • Media
    • FSA & HSA Eligibility
    • Patient Assistance Program
    • Contact Us
  • Products
    • Kidney C.O.P.®
    • Veloxa™ Very Low Oxalate Teas
    • Low Oxalate Cookbook
  • Order Now

Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.,

Abstract

BACKGROUND AND PURPOSE:

To evaluate the efficacy of potassium citrate treatment in preventing stone recurrences and residual fragments after shockwave lithotripsy (SWL) for lower pole calcium oxalate urolithiasis.

PATIENTS AND METHODS:

One hundred ten patients who underwent SWL because of lower caliceal stones and who were stone free or who had residual stone 4 weeks later were
enrolled in the study. The average patient age was 41.7 years. All patients had documented simple calcium oxalate lithiasis without urinary tract infec􀆟on and with normal renal morphology and function. Four weeks after SWL, patients who were stone free (N = 56) and patients who had residual stones (N = 34) were independently randomized into two subgroups that were matched for sex, age, and urinary values of citrate, calcium, and uric acid. One group was given oral potassium citrate 60 mEq per day, and the other group served as controls.

RESULTS:

In patients who were stone free after SWL and receiving medical treatment, the stone recurrence rate at 12 months was 0 whereas untreated patients showed a 28.5% stone recurrence rate (P < 0.05). Similarly, in the residual fragment group, the medically treated patients had a significantly greater remission rate than the untreated patients (44.5 v 12.5%; P < 0.05).

CONCLUSION:

Potassium citrate therapy significantly alleviated calcium oxalate stone activity after SWL for lower pole stones in patients who were stone free. An important observation was the beneficial effect of medical treatment on stone activity after SWL among patients with residual calculi.

Buy Kidney C.O.P.® Direct from the Manufacturer from Our 100% Secure Site

Order now

Also Available for Purchase at Amazon.com and Walmart.com

Paid link above. As an Amazon Associate, Calcium Oxalate Labs earns from qualifying purchases.

*In vitro tests show that patented formula inhibits the rate of calcium oxalate crystal growth by 99%. Kidney C.O.P.® Patent: Compositions and methods to inhibit kidney stone growth.

**These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

***Kidney C.O.P.® patented formulation contains clinically researched ingredients. Each active ingredient in Kidney C.O.P. (or a combination of the ingredients) have been clinically tested and shown, to varying degrees of potential, to inhibit the rate of calcium oxalate crystal growth.

****Many of Kidney C.O.P.’s active ingredients (or combination of) have been tested in clinical studies & have shown to have an effect inhibiting calcium oxalate crystal growth. Many of these clinical studies are found in the five patents: 9,233,135; 9,492,491; 9,623,006; 9,789,152; 10,471,115 – pgs 1 – 3 of each patent.

Caution: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur.

Menu
  • The Science
  • Safety & Use
  • About Us
  • FAQs
  • Guarantee
  • Blog
  • Contact Us
  • ORDER NOW
Copyright © 2025 — Calcium Oxalate Labs, Inc. • All rights reserved. WordPress Website Design & Development by KEX Consulting
Menu
  • sitemap
  • Privacy Policy
  • Terms and Conditions
Master Card
Visa
American Express

Attention Kidney C.O.P. Customers!

See Our NEW Low Oxalate Product
Veloxa™​ | Very Low Oxalate Tea​

Great Tasting Teas Low in Oxalate

   

Choose from 3 Delicious Tea Blends

Learn more about Veloxa™​ | Very Low Oxalate Tea​ – click here